BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27891733)

  • 1. Generalized granulomatous dermatitis following Mycobacterium w (Mw) immunotherapy in lepromatous leprosy.
    Khullar G; Narang T; Nahar Saikia U; Dogra S
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline successfully treats exaggerated granulomatous hypersensitivity reaction to Mw immunotherapy.
    Vinay K; Narang T; Saikia UN; Kumaran MS; Dogra S
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27891740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy.
    Zaheer SA; Mukherjee R; Ramkumar B; Misra RS; Sharma AK; Kar HK; Kaur H; Nair S; Mukherjee A; Talwar GP
    J Infect Dis; 1993 Feb; 167(2):401-10. PubMed ID: 8421173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histopathological evaluation of the effect of addition of immunotherapy with Mw vaccine to standard chemotherapy in borderline leprosy.
    Kamal R; Natrajan M; Katoch K; Arora M
    Indian J Lepr; 2012; 84(4):287-306. PubMed ID: 23720894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lichen scrofulosorum in a patient with lepromatous leprosy after BCG immunotherapy.
    Kumaran MS; Dogra S; Kaur I; Kumar B
    Lepr Rev; 2005 Jun; 76(2):170-4. PubMed ID: 16038252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized lepromatous leprosy and its response to chemo-immunotherapy.
    Beena KR; Zaheer SA; Guleria I; Mukherjee R; Talwar GP; Mukherjee A; Ramesh V; Misra RS
    Int J Dermatol; 1994 Jan; 33(1):64-7. PubMed ID: 8112948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological changes with combined chemotherapy and immunotherapy in highly bacillated lepromatous leprosy.
    Natarajan M; Katoch K; Bagga AK; Katoch VM
    Acta Leprol; 1992; 8(2):79-86. PubMed ID: 1293915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthomatous macrophages in bone marrow biopsies: systemic manifestation of mycobacterioses.
    Oliveira CC; NiƩro-Melo L; Domingues MAC
    Ann Hematol; 2017 Jul; 96(7):1237-1238. PubMed ID: 28508934
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy with Mycobacterium w vaccine decreases the incidence and severity of type 2 (ENL) reactions.
    Zaheer SA; Misra RS; Sharma AK; Beena KR; Kar HK; Mukherjee A; Mukherjee R; Walia R; Talwar GP
    Lepr Rev; 1993 Mar; 64(1):7-14. PubMed ID: 8464320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional immunotherapy with killed Mycobacterium indicus pranii vaccine for the treatment of extensive cutaneous warts.
    Singh S; Chouhan K; Gupta S
    Indian J Dermatol Venereol Leprol; 2014; 80(6):509-14. PubMed ID: 25382507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borderline Lepromatous Leprosy: Cutaneous Manifestation and Type 1 Reversal Reaction.
    Hattori M; Motegi S; Amano H; Ishii N; Ishikawa O
    Acta Derm Venereol; 2016 Mar; 96(3):422-3. PubMed ID: 26439279
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients.
    Talwar GP; Zaheer SA; Mukherjee R; Walia R; Misra RS; Sharma AK; Kar HK; Mukherjee A; Parida SK; Suresh NR
    Vaccine; 1990 Apr; 8(2):121-9. PubMed ID: 2336873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated cutaneous BCG infection following BCG immunotherapy in patients with lepromatous leprosy.
    Khullar G; Narang T; Sharma K; Saikia UN; Dogra S
    Lepr Rev; 2015 Jun; 86(2):180-5. PubMed ID: 26502690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sub-polar lepromatous leprosy localized to the face.
    George M; Rajan U; George S; Pakran J; Thomas S
    Dermatol Online J; 2010 Sep; 16(9):8. PubMed ID: 20875329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nodular dermohypodermatitis of the right arm].
    Vandenbos F; Rahelinirina V; Dellamonica P
    Presse Med; 2005 Apr; 34(8):617. PubMed ID: 15962505
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of bacilliferous BL/LL cases with combined chemotherapy and immunotherapy.
    Katoch K; Katoch VM; Natrajan M; Bhatia AS; Sreevatsa ; Gupta UD; Sharma VD; Shivannavar CT; Patil MA; Bharadwaj VP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):202-12. PubMed ID: 7602215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local hyperthermia therapy for refractory cutaneous Mycobacterium marinum infection.
    Lee CN; Lee JY
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29028142
    [No Abstract]   [Full Text] [Related]  

  • 19. Histologic responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG.
    Meyers WM; McDougall AC; Fleury RN; Neves R; Reyes O; Binford CH
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):302-9. PubMed ID: 3045226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterial dermatitis.
    Lemarie SL
    Vet Clin North Am Small Anim Pract; 1999 Nov; 29(6):1291-301. PubMed ID: 10563000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.